Effect of anticoagulation on renal function and protein excretion in experimental acute ischemic renal failure.
Female Sprague-Dawley rats underwent right nephrectomy and 40 min left renal artery occlusion (RAO). After 15 min of reflow, polyethylene glycol 1000 (PEG1000) was infused to induce osmotic diuresis and to enable glomerular filtration rate (GFR) measurements. Urine was collected during a 90 min period, and the concentrations of PEG1000, albumin, IgG, IgM and fibrin(ogen)/degradation products (FIB) were assessed both in plasma and urine by radial immuno diffusion technique Groups of rats were subjected to saline + RAO, warfarin + RAO or sham-operation. GFR as measured by PEG1000 clearance averaged 0.61, 0.036 and 0.094 mL/min/100g BW/kidney in sham-operated, saline + RAO and warfarin + RAO rats, respectively. Urinary excretion of albumin and IgG increased substantially in both ischemic groups. IgM was not detected in any of the urine samples. FIB excretion was lowest in the saline + RAO group, possibly due to retention of FIB-containing obstructions in the tubules. Rats subjected to warfarin + RAO had significantly higher excretion of FIB. This result suggests that warfarin does not prevent the glomerular sieving of macromolecules in the glomerular filter, but reduces tubular obstruction by preventing fibrin formation, which may explain its positive effect on GFR.
Druid
H
H
Division of Forensic Medicine, Faculty of Health Sciences, Linköping University, Sweden. henrik.druid@rm.rmv.se
Nilsson
I
I
Rammer
L
L
Skude
G
G
D058186:Acute Kidney Injury / Q000097:blood / Q000503:physiopathology*; D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology*; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D005919:Glomerular Filtration Rate; D007668:Kidney / Q000503:physiopathology*; D011507:Proteinuria / Q000517:prevention & control; D051381:Rats; D017207:Rats, Sprague-Dawley; D012078:Renal Artery Obstruction / Q000097:blood / Q000503:physiopathology*; D014859:Warfarin / Q000494:pharmacology*
D000925:Anticoagulants; D005338:Fibrin Fibrinogen Degradation Products; D014859:Warfarin